(Q43871998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Andrea Gallina

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Umberto Capitanio

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alexandre Mottrie

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

9

Francesco Montorsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

10

Alberto Briganti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

4

Andrea Salonia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

8

Patrizio Rigatti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

Nazareno Suardi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

6

Massimo Freschi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

12 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

973-980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751185%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Early outcomes of active surveillance for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Delayed versus immediate surgical intervention and prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

The role of biopsy core number in selecting prostate cancer patients for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Insignificant prostate cancer and active surveillance: from definition to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

20-year outcomes following conservative management of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

A multi-institutional evaluation of active surveillance for low risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Impact of Patient Age on Biochemical Recurrence Rates Following Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021

Predictors of histological disease progression in untreated, localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021

Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26234

7 January 2021